Listeners Club

Forgot Password

Not a Member? Sign up here!


Local Headlines

COVID-19 data for Greater Danbury area updated

The number of COVID-19 cases reported by Danbury to the Connecticut Department of Public Health dropped this week compared to last.  Rates held steady in all other Greater Danbury area municipalities.  According to the report ending October 3rd, there were 48 cases in Danbury, Bethel reported 17, and Brookfield had 17.  There were 16 COVID cases in New Milford, 7 in New Fairfield, 15 in Newtown, 5 in Redding while Ridgefield had 11. 


Most Greater Danbury area towns reported about 50 to 150 COVID-19 tests to the state Department of Public Health over the last 7 days with positivity of 7 to 13 percent.  New Milford reported 250 tests and Danbury reported 587, about the same as last week.  Newtown for several weeks has been alternating between reporting about 600 tests or just 200.  At home tests are not reported. 

The test positivity rates are:

New Fairfield  7.4 percent

New Milford 7.4 percent

Danbury 7.7 percent

Ridgefield 9 percent

Newtown 9.5 percent

Redding 9.8 percent

Bethel 11.8 percent

Brookfield 13.4 percent


New state data released Thursday shows a slight increase in COVID-19 positivity statewide compared to last week.  The rolling 7-day average is 9.5 percent, 3 tenths of a percent higher than the week before. There were 3,400 positive COVID cases reported to the state out of about 36,000 tests, slightly less than last week. The number of people in Connecticut hospitals testing positive for COVID-19 over the last 7 days increased by 5.  The inpatient total is 388, with 32-percent not fully vaccinated. The number COVID-associated deaths in Connecticut has grown by 20 since last Thursday.


The BA5 Omicron subvariant of COVID-19 continues to make up the majority of the cases sent for genomic sequencing in Connecticut, according to the latest report. 83.8 percent of samples were BA5, while 12.9 percent were identified as BA4.  A new subvariant, BF7 is now being reported, identified in 1.7 percent of samples tested in Connecticut. The rest sent for sequencing were identified as BA 2.